Advanced search
Publication Cover
Expert Opinion on Therapeutic Targets Volume 15, 2011 - Issue 9
Submit an article Journal homepage
847
Views
60
CrossRef citations to date
0
Altmetric
Reviews

Osteopontin: a potentially important therapeutic target in cancer

Mansoor Ahmed Yale University, CT, USA
, PhD,
Reeti BeheraH Lee Moffitt Cancer Center and Research Institute, FL, USA
, PhD,
Goutam ChakrabortyMemorial Sloan-Kettering Cancer Center, New York, USA
, PhD,
Shalini JainThe University of Texas MD Anderson Cancer Center, Houston, Texas, USA
, PhD,
Vinit KumarH Lee Moffitt Cancer Center and Research Institute, FL, USA
, MSc,
Priyanka Sharma University of California, Riverside, CA, USA
, MSc,
Anuradha BulbuleNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, BSc,
Smita KaleNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Santosh KumarNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Rosalin MishraNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Remya RajaNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Supriya SaraswatiNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Rajinder KaurNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Gowrishankar SoundararajanNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Dhiraj KumarNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Dhanashri ThoratNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Megha SanyalNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Anuja RamdasiNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc,
Pompom GhoshNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, MSc &
Gopal C KunduNational Center for Cell Science, NCCS Complex, Ganeshkhind, Pune 411 007, India+91 20 25708103; +91 20 25692259; [email protected] Present Address:
, PhD show all
Pages 1113-1126 | Published online: 25 Jul 2011

Citations (60)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Xiaoping Ouyang, Yumin Huang, Xing Jin, Wei Zhao, Tao Hu, Feng Wu & Jianan Huang. (2018) Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer. OncoTargets and Therapy 11, pages 5933-5941.
Read now
Biao Zeng, Min Zhou, Huan Wu & Zhengai Xiong. (2018) SPP1 promotes ovarian cancer progression via Integrin β1/FAK/AKT signaling pathway. OncoTargets and Therapy 11, pages 1333-1343.
Read now
Marta Szajnik, Małgorzata Czystowska-Kuźmicz, Esther Elishaev & Theresa L. Whiteside. (2016) Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma. Expert Review of Molecular Diagnostics 16:8, pages 811-826.
Read now
Monalisa Bandopadhyay, Anuradha Bulbule, Ramesh Butti, Goutam Chakraborty, Priyanka Ghorpade, Pompom Ghosh, Mahadeo Gorain, Smita Kale, Dhiraj Kumar, Santosh Kumar, Kumar VS Totakura, Gaurab Roy, Priyanka Sharma, Dattatrya Shetti, Gowrishankar Soundararajan, Dhanashri Thorat, Deepti Tomar, Radha Nalukurthi, Remya Raja, Rosalin Mishra, Amit S Yadav & Gopal C Kundu. (2014) Osteopontin as a therapeutic target for cancer. Expert Opinion on Therapeutic Targets 18:8, pages 883-895.
Read now

Articles from other publishers (56)

Elisabeth Digifico, Marco Erreni, Laura Mannarino, Sergio Marchini, Aldo Ummarino, Clément Anfray, Luca Bertola, Camilla Recordati, Daniela Pistillo, Massimo Roncalli, Paola Bossi, Paolo Andrea Zucali, Maurizio D’Incalci, Cristina Belgiovine & Paola Allavena. (2023) Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma. Frontiers in Immunology 14.
Crossref
José Ignacio Nolazco, Simon John Christoph Soerensen & Benjamin I. Chung. (2023) Biomarkers for the Detection and Surveillance of Renal Cancer. Urologic Clinics of North America 50:2, pages 191-204.
Crossref
Haitao Zhong, Le Yang, Qingshang Zeng, Weidong Chen, Haibo Zhao, Linlin Wu, Lei Qin & Qing-Qing Yu. (2023) Machine Learning Predicts the Oxidative Stress Subtypes Provide an Innovative Insight into Colorectal Cancer. Oxidative Medicine and Cellular Longevity 2023, pages 1-12.
Crossref
Janina Janssen, Anna Oevermann, Ingrid Walter, Alexander Tichy, Stefan Kummer & Gabriele Gradner. (2023) Osteopontin and Ki-67 expression in World Health Organization graded canine meningioma. Journal of Comparative Pathology 201, pages 41-48.
Crossref
Xuan Yi, Linlin Luo, Yanzhen Zhu, Hong Deng, Huitian Liao, Yang Shen & Yan Zheng. (2022) SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma. Cancer Cell International 22:1.
Crossref
Muhammad Usama Saeed, Nazim Hussain, Iqra Zulfiqar, Ali Raza, Mohsin Ahmad Ghauri & Muhammad Bilal. (2022) Tumor cell dormancy: Molecular mechanisms, and pharmacological approaches to target dormant cells for countering tumor. Journal of Drug Delivery Science and Technology 75, pages 103645.
Crossref
E. S Gozman & N. A Makarova. (2021) HISTOLOGICAL, GENETIC, IMMUNOHISTOCHEMICAL MARKERS OF BORDERLINE OVARIAN TUMORS. Journal of Volgograd State Medical University 18:3, pages 8-14.
Crossref
Weihua Chen, Zhen Sun & Lehui Lu. (2020) Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives. Angewandte Chemie International Edition 60:11, pages 5626-5643.
Crossref
Weihua Chen, Zhen Sun & Lehui Lu. (2020) Zielgerichtete Wirkstoffe für die Krebstherapie: Aktuelle Entwicklungen und Perspektiven. Angewandte Chemie 133:11, pages 5686-5705.
Crossref
Yiming Zhu, Liang Shi, Ping Chen, Yingli Zhang & Tao Zhu. (2020) Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis. World Journal of Surgical Oncology 18:1.
Crossref
Isabel J. Dionísio de Sousa, Durval S. Marques, Catarina Príncipe, Raquel V. Portugal, Sule Canberk, Hugo Prazeres, José M. Lopes, Etel R. P. Gimba, Raquel T. Lima & Paula Soares. (2020) Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer. Diagnostics 10:8, pages 525.
Crossref
Amit S. Yadav, N. Naga Venkata Radharani, Mahadeo Gorain, Anuradha Bulbule, Dattatrya Shetti, Gaurab Roy, Thejus Baby & Gopal C. Kundu. (2020) RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer. Nanoscale 12:19, pages 10664-10684.
Crossref
Raghu Bhushan, Lukas Altinbas, Marten Jäger, Marcin Zaradzki, Daniel Lehmann, Bernd Timmermann, Nicholas P. Clayton, Yunxiang Zhu, Klaus Kallenbach, Georgios Kararigas & Peter N. Robinson. (2019) An integrative systems approach identifies novel candidates in Marfan syndrome‐related pathophysiology. Journal of Cellular and Molecular Medicine 23:4, pages 2526-2535.
Crossref
Ramesh Butti, Vinoth Prasanna Gunasekaran, Totakura V.S. Kumar, Pinaki Banerjee & Gopal C. Kundu. (2019) Breast cancer stem cells: Biology and therapeutic implications. The International Journal of Biochemistry & Cell Biology 107, pages 38-52.
Crossref
Dhiraj Kumar, Saikat Haldar, Mahadeo Gorain, Santosh Kumar, Fayaj A. Mulani, Amit S. Yadav, Lucio Miele, Hirekodathakallu V. Thulasiram & Gopal C. Kundu. (2018) Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway. BMC Cancer 18:1.
Crossref
Eunji Im, Changhwan Yeo & Eun-Ok Lee. (2018) Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells. Life Sciences 209, pages 259-266.
Crossref
Amit S. Yadav, Poonam R. Pandey, Ramesh Butti, N. N. V. Radharani, Shamayita Roy, Shaileshkumar R. Bhalara, Mahadeo Gorain, Gopal C. Kundu & Dhiraj Kumar. (2018) The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation. Frontiers in Oncology 8.
Crossref
Solomon L. Woldu, Ryan C. Hutchinson, Laura-Maria Krabbe, Oner Sanli & Vitaly Margulis. (2017) The Rho GTPase signalling pathway in urothelial carcinoma. Nature Reviews Urology 15:2, pages 83-91.
Crossref
Debolina Chakraborty, Thangaraj Soundara Viveka, Krishnamurthy Arvind, Vidyarani Shyamsundar, Murhekar Kanchan, Sruthi Ann Alex, N. Chandrasekaran, Ramshankar Vijayalakshmi & Amitava Mukherjee. (2018) A facile gold nanoparticle–based ELISA system for detection of osteopontin in saliva: Towards oral cancer diagnostics. Clinica Chimica Acta 477, pages 166-172.
Crossref
Cong Xu, Hua Li, Miao Yin, Tao Yang, Liguo An & Guiwen Yang. (2017) Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis. Oncotarget 8:58, pages 98394-98404.
Crossref
Chi Gu Kang, Eunji Im, Hyo-Jeong Lee & Eun-Ok Lee. (2017) Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice. Bioorganic & Medicinal Chemistry Letters 27:9, pages 1914-1918.
Crossref
Syed A. Hussain, Daniel H. Palmer, Wing-Kin Syn, Joseph J. Sacco, Richard M.D. Greensmith, Taha Elmetwali, Vijay Aachi, Bryony H. Lloyd, Puthen V. Jithesh, John Arrand, Darren Barton, Jawaher Ansari, D. Ross Sibson & Nicholas D. James. (2017) Gene expression profiling in bladder cancer identifies potential therapeutic targets. International Journal of Oncology 50:4, pages 1147-1159.
Crossref
Mahvash Tavassoli & Yae-eun Suh. 2017. Squamous cell Carcinoma. Squamous cell Carcinoma 59 95 .
Fuquan Jin, Keguo Jiang, Shuang Ji, Li Wang, Zhaofei Ni, Fuqiang Huang, Chunjia Li, Rongrong Chen, Hongbing Zhang, Zhongdong Hu & Xiaojun Zha. (2016) Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex. Human Molecular Genetics, pages ddw397.
Crossref
Farshid Dayyani, Amado J. Zurita, Graciela M. Nogueras-González, Rebecca Slack, Randall E. Millikan, John C. Araujo, Gary E. Gallick, Christopher J. Logothetis & Paul G. Corn. (2016) The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study. BMC Cancer 16:1.
Crossref
Mathieu Rouanne, Julien Adam, Aïcha Goubar, Angélique Robin, Caroline Ohana, Emilie Louvet, Jiemin Cormier, Olaf Mercier, Peter Dorfmüller, Soly Fattal, Vincent Thomas de Montpreville, Thierry Lebret, Philippe Dartevelle, Elie Fadel, Benjamin Besse, Ken André Olaussen, Christian Auclair & Jean-Charles Soria. (2016) Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer. BMC Cancer 16:1.
Crossref
Mansoor Ahmed, Joseph L. Sottnik, Garrett M. Dancik, Divya Sahu, Donna E. Hansel, Dan Theodorescu & Martin A. Schwartz. (2016) An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression. Cancer Cell 30:3, pages 432-443.
Crossref
Jana Rychlíková, Marek Vecka, Marie Jáchymová, Jaroslav Macášek, Petr Hrabák, Miroslav Zeman, Lucie Vávrová, Jan Řoupal, Tomáš Krechler & Aleš ák. (2016) Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. Cancer Biomarkers 17:1, pages 55-65.
Crossref
Nai-Wei Yao, Chen Chang, Hsiu-Ting Lin, Chen-Tung Yen & Jeou-Yuan Chen. (2016) Functional assessment of glioma pathogenesis by in vivo multi-parametric magnetic resonance imaging and in vitro analyses. Scientific Reports 6:1.
Crossref
Andrew J. Sawyer & Themis R. Kyriakides. (2016) Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Advanced Drug Delivery Reviews 97, pages 56-68.
Crossref
Chi Gu Kang, Hyo-Jeong Lee, Sung-Hoon Kim & Eun-Ok Lee. (2015) Zerumbone Suppresses Osteopontin-Induced Cell Invasion Through Inhibiting the FAK/AKT/ROCK Pathway in Human Non-Small Cell Lung Cancer A549 Cells. Journal of Natural Products 79:1, pages 156-160.
Crossref
Laura E Thomas, Jincy Winston, Ellie Rad, Matthew Mort, Kayleigh M Dodd, Andrew R Tee, Fionnuala McDyer, Stephen Moore, David N Cooper & Meena Upadhyaya. (2015) Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours. Human Genomics 9:1.
Crossref
Su-Hyung Lee, Jun-Won Park, Du-Min Go, Hark Kyun Kim, Hyo-Jung Kwon, Sang-Uk Han & Dae-Yong Kim. (2015) Ablation of osteopontin suppresses N -methyl- N -nitrosourea and Helicobacter pylori -induced gastric cancer development in mice . Carcinogenesis, pages bgv144.
Crossref
Virginie Lamour, Aurélie Henry, Jérôme Kroonen, Marie-Julie Nokin, Zofia von Marschall, Larry W. Fisher, Tieu-Lan Chau, Alain Chariot, Marc Sanson, Jean-Yves Delattre, Andrei Turtoi, Olivier Peulen, Bernard Rogister, Vincent Castronovo & Akeila Bellahcène. (2015) Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo . International Journal of Cancer 137:5, pages 1047-1057.
Crossref
Won-Young Cho, Seong-Ho Hong, Bijay Singh, Mohammad Ariful Islam, Somin Lee, Ah Young Lee, Nomundelger Gankhuyag, Ji-Eun Kim, Kyeong-Nam Yu, Kwang-Ho Kim, Young-Chan Park, Chong-Su Cho & Myung-Haing Cho. (2015) Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA. European Journal of Pharmaceutics and Biopharmaceutics 94, pages 450-462.
Crossref
Zhi-De Hu, Ting-Ting Wei, Min Yang, Ning Ma, Qing-Qin Tang, Bao-Dong Qin, Hai-Tao Fu & Ren-Qian Zhong. (2015) Diagnostic Value of Osteopontin in Ovarian Cancer: A Meta-Analysis and Systematic Review. PLOS ONE 10:5, pages e0126444.
Crossref
Chi Gu Kang, Hwa Jeong Han, Hyo-Jeong Lee, Sung-Hoon Kim & Eun-Ok Lee. (2015) Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines. Bioorganic & Medicinal Chemistry Letters 25:9, pages 1956-1960.
Crossref
Keunhee OhMyung Won SeoYoung Whan KimDong-Sup Lee. (2015) Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated Mice. Immune Network 15:3, pages 142.
Crossref
Tae-kyung Kwak, Eun Jung Sohn, Sunhee Kim, Gunho Won, Jeong-Un Choi, Kwon Jeong, Myoungseok Jeong, Oh Sung Kwon & Sung-Hoon Kim. (2014) Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells. BMC Complementary and Alternative Medicine 14:1.
Crossref
Alexandra Naba, Karl R Clauser, Charles A Whittaker, Steven A Carr, Kenneth K Tanabe & Richard O Hynes. (2014) Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer 14:1.
Crossref
Tatiana M Tilli, Akeila Bellahcène, Vincent Castronovo & Etel R P Gimba. (2014) Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines. BMC Cancer 14:1.
Crossref
He Zhang, Hong-bing Liu, Dong-mei Yuan, Zhao-feng Wang, Yun-fen Wang & Yong Song. (2014) Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer. BMC Cancer 14:1.
Crossref
I-Shan Hsieh, Rong-Sen Yang & Wen-Mei Fu. (2014) Osteopontin Upregulates the Expression of Glucose Transporters in Osteosarcoma Cells. PLoS ONE 9:10, pages e109550.
Crossref
Yi-Peng Han, Chen-Kai Ma, Shen-Qi Wang, Atsushi Enomoto, Yang Zhao, Masahide Takahashi & Jie Ma. (2014) Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors. Journal of Neuro-Oncology 119:2, pages 343-351.
Crossref
R Raja, S Kale, D Thorat, G Soundararajan, K Lohite, A Mane, S Karnik & G C Kundu. (2013) Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis. Oncogene 33:16, pages 2053-2064.
Crossref
Anna M. Zawadzka, Birgit Schilling, Michael P. Cusack, Alexandria K. Sahu, Penelope Drake, Susan J. Fisher, Christopher C. Benz & Bradford W. Gibson. (2014) Phosphoprotein Secretome of Tumor Cells as a Source of Candidates for Breast Cancer Biomarkers in Plasma. Molecular & Cellular Proteomics 13:4, pages 1034-1049.
Crossref
Ata Türker Arıkök, Evrim Önder, Hakan Seçkin, Ayper Kaçar, Ramazan Fesli, Ayşe Selcen Oğuz & Murat Alper. (2013) Osteopontin expressions correlate with WHO grades and predict recurrence in meningiomas. Brain Tumor Pathology 31:2, pages 94-100.
Crossref
Subramaniam Sivakumar & Sivasitambaram Niranjali Devaraj. (2014) Tertiary structure prediction and identification of druggable pocket in the cancer biomarker – Osteopontin-c. Journal of Diabetes & Metabolic Disorders 13:1.
Crossref
DHANASHRI THORAT, ASUTOSH SAHU, REETI BEHERA, KIRTI LOHITE, SANJAY DESHMUKH, ANUPAMA MANE, SWAPNIL KARNIK, SUHASCHANDRA DOKE & GOPAL C. KUNDU. (2013) Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkers. Oncology Letters 6:6, pages 1559-1564.
Crossref
Ozgur Mete, Caroline Hayhurst, Hussein Alahmadi, Eric Monsalves, Hasan Gucer, Fred Gentili, Shereen Ezzat, Sylvia L. Asa & Gelareh Zadeh. (2013) The Role of Mediators of Cell Invasiveness, Motility, and Migration in the Pathogenesis of Silent Corticotroph Adenomas. Endocrine Pathology 24:4, pages 191-198.
Crossref
ARASH MINAI-TEHRANI, SEUNG-HEE CHANG, SEUNG BUM PARK & MYUNG-HAING CHO. (2013) The O-glycosylation mutant osteopontin alters lung cancer cell growth and migration in vitro and in vivo. International Journal of Molecular Medicine 32:5, pages 1137-1149.
Crossref
Virginie Lamour, Marie-Julie Nokin, Aurélie Henry, Vincent Castronovo & Akeila Bellahcène. (2013) Les protéines SIBLING. médecine/sciences 29:11, pages 1018-1025.
Crossref
Santosh Kumar, Priyanka Sharma, Dhiraj Kumar, Goutam Chakraborty, Mahadeo Gorain & Gopal C. Kundu. (2013) Functional Characterization of Stromal Osteopontin in Melanoma Progression and Metastasis. PLoS ONE 8:7, pages e69116.
Crossref
Katherine E. Poruk, Matthew A. Firpo, Courtney L. Scaife, Douglas G. Adler, Lyska L. Emerson, Kenneth M. Boucher & Sean J. Mulvihill. (2013) Serum Osteopontin and Tissue Inhibitor of Metalloproteinase 1 as Diagnostic and Prognostic Biomarkers for Pancreatic Adenocarcinoma. Pancreas 42:2, pages 193-197.
Crossref
Seon-Sook HanSeung-Joon LeeWoo Jin KimDong Ryeol RyuJun Yeon WonShinyoung ParkMyeong Ju Cheon. (2013) Plasma Osteopontin Is a Useful Diagnostic Biomarker for Advanced Non-Small Cell Lung Cancer. Tuberculosis and Respiratory Diseases 75:3, pages 104.
Crossref
Anette M. Høye, John R. Couchman, Ulla M. Wewer, Kiyoko Fukami & Atsuko Yoneda. (2012) The newcomer in the integrin family: Integrin α9 in biology and cancer. Advances in Biological Regulation 52:2, pages 326-339.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.